Compass Therapeutics, Inc. (CMPX)
NASDAQ · Manufacturing · Biological products, (no diagnostic substances)
CMPX price, last 12 months
Key stats
- Previous close
- $1.14
- Open
- $1.17
- Day range
- $1.12 – $1.20
- 52-week range
- $1.10 – $6.88
- Volume
- 3.5M
- Avg volume (20 days)
- 4.6M
- Market cap
- $203.5M
Performance
Technicals and fundamentals
About Compass Therapeutics, Inc.
Compass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to target the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-A, Bispecific, and CTX-8371.
- Sector
- Manufacturing
- Industry
- Biological products, (no diagnostic substances)
- Listed on
- NASDAQ
- Market cap
- $203.5M